Oct 19, 09
|
| NEW STORY |
| 08:00 ET |
Halozyme to Present at the BIOCOM Investor Conference on October 26
|
|
Jan 06, 09
|
| 08:00 ET |
Halozyme Receives $5.5 Million Payment From Baxter
|
|
Jan 05, 09
|
| 08:00 ET |
Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients
|
|
Dec 10, 08
|
| 08:00 ET |
Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
|
|
Dec 08, 08
|
| 08:00 ET |
Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
|
|
Nov 06, 08
|
| 16:05 ET |
Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
|
|
Nov 03, 08
|
| 07:00 ET |
Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
|
|
Oct 30, 08
|
| 13:00 ET |
Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
|
|
Oct 22, 08
|
| 08:00 ET |
Halozyme Therapeutics to Present at Upcoming Investor Conferences
|
|
Oct 01, 08
|
| 08:00 ET |
Halozyme Therapeutics to Host Research Day for Investors and Analysts
|
|
Sep 23, 08
|
| 08:00 ET |
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
|
|
Sep 10, 08
|
| 08:00 ET |
Halozyme Therapeutics to Present at Upcoming Investor Conferences
|
|
Sep 02, 08
|
| 08:00 ET |
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
|
|
Aug 08, 08
|
| 08:00 ET |
Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
|
|
Jul 31, 08
|
| 16:30 ET |
Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8
|
|
Jul 22, 08
|
| 08:00 ET |
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
|
|
Jun 30, 08
|
| 16:39 ET |
Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
|
|
Jun 18, 08
|
| 08:00 ET |
Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
|
|
Jun 09, 08
|
| 08:00 ET |
Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
|
|
May 19, 08
|
| 16:21 ET |
Halozyme Therapeutics Presents Pre-Clinical Studies on Dermal Remodeling With HTI-501, a Lysosomal Proteinase
|
|
May 08, 08
|
| 17:00 ET |
Halozyme Therapeutics Reports 2008 First Quarter Financial Results
|
|
May 06, 08
|
| 08:00 ET |
Halozyme Therapeutics to Present at Upcoming Investor Conferences
|
|
May 01, 08
|
| 08:00 ET |
Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
|
|
Apr 16, 08
|
| 08:00 ET |
Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
|
|
Apr 15, 08
|
| 08:00 ET |
Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
|
|
Mar 13, 08
|
| 17:00 ET |
Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
|
|
Mar 12, 08
|
| 08:00 ET |
Halozyme Therapeutics to Present at the Cowen and Company 28th Annual Health Care Conference
|
|
Mar 10, 08
|
| 16:15 ET |
Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
|
|
Mar 07, 08
|
| 08:00 ET |
Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
|
|
Feb 05, 08
|
| 08:00 ET |
Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
|
|
Jan 08, 08
|
| 08:00 ET |
Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
|
|
Nov 19, 07
|
| 08:00 ET |
Halozyme Therapeutics to Present at Lazard Capital Markets Fourth Annual Healthcare Conference
|
|
Nov 14, 07
|
| 16:15 ET |
Halozyme Therapeutics Amends Stockholder Rights Plan
|
|
Nov 13, 07
|
| 16:15 ET |
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
|
|
Nov 12, 07
|
| 16:15 ET |
Halozyme Therapeutics Added to Nasdaq Biotech Index
|
|
Nov 08, 07
|
| 16:30 ET |
Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
|
|
Nov 01, 07
|
| 16:31 ET |
Halozyme Therapeutics to Hold Business Update Conference Call on November 9
|
|
Sep 25, 07
|
| 16:15 ET |
Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
|
|
Sep 13, 07
|
| 16:15 ET |
Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
|
|
Aug 28, 07
|
| 08:00 ET |
Halozyme Therapeutics to Present at Roth Capital Partners 2007 New York Conference
|
|
Aug 09, 07
|
| 16:16 ET |
Halozyme Therapeutics Reports 2007 Second Quarter Financial Results
|
|
Aug 02, 07
|
| 08:00 ET |
Halozyme Therapeutics to Hold Business Update Conference Call on August 10
|
|
Jul 17, 07
|
| 08:00 ET |
Halozyme Therapeutics Names Walter H. Bee, PhD Vice President, Preclinical Development
|
|
Jul 09, 07
|
| 16:15 ET |
Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
|
|
May 31, 07
|
| 08:00 ET |
Halozyme Therapeutics Announces Closing of $32.1 Million Private Financing
|
|
May 16, 07
|
| 08:00 ET |
Halozyme Therapeutics Names Randal J. Kirk and Kathryn E. Falberg to Board of Directors
|
|
May 14, 07
|
| 16:15 ET |
Halozyme Therapeutics and Roche to Deliver Joint Presentation at SCRIP Conference:
|
|
May 10, 07
|
| 16:15 ET |
Halozyme Therapeutics Reports 2007 First Quarter Financial Results
|
|
May 07, 07
|
| 08:00 ET |
Halozyme Therapeutics to Hold Business Update Conference Call on May 11
|
|
May 02, 07
|
| 08:00 ET |
Halozyme Therapeutics to Present at May Investment Conferences
|
|
Apr 30, 07
|
| 08:00 ET |
Halozyme Therapeutics Announces Nasdaq Global Market Listing Approval
|
|
Apr 24, 07
|
| 08:00 ET |
Halozyme Therapeutics Announces $32.1 Million Private Financing
|
|
Mar 13, 07
|
| 17:00 ET |
Halozyme Therapeutics Adopts SEC Rule 10b5-1 Policy
|
|
Mar 08, 07
|
| 08:00 ET |
Halozyme Therapeutics Reports Fourth Quarter and Year End 2006 Financial Results
|
|
Mar 07, 07
|
| 08:00 ET |
Halozyme Therapeutics to Present at the Cowen & Company 27th Annual Health Care Conference
|
|
Mar 06, 07
|
| 08:00 ET |
Halozyme Therapeutics to Hold 2006 Fourth Quarter and Year End Conference Call on March 8
|
|
Feb 14, 07
|
| 08:00 ET |
Halozyme and Baxter Expand Global HYLENEX Collaboration
|
|
Feb 13, 07
|
| 08:00 ET |
Halozyme therapeutics to Present at the Roth Capital Partners 19th Annual OC Conference
|
|
Jan 22, 07
|
| 08:00 ET |
Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
|
|
Jan 03, 07
|
| 08:00 ET |
Halozyme Therapeutics to Present at the JPMorgan 25th Annual Healthcare Conference
|
|
Nov 27, 06
|
| 08:00 ET |
Halozyme Therapeutics Completes Enrollment of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
|
|
Nov 20, 06
|
| 08:00 ET |
Halozyme Therapeutics to Present at the Lazard Capital Markets Third Annual Life Sciences Conference
|
|
Nov 09, 06
|
| 16:05 ET |
Halozyme Therapeutics Reports Third Quarter 2006 Financial Results
|
|
Nov 08, 06
|
| 16:00 ET |
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
|
|
Nov 01, 06
|
| 13:55 ET |
Halozyme Therapeutics to Present at the Rodman and Renshaw 8th Annual Healthcare Conference
|
|
Oct 26, 06
|
| 08:00 ET |
New Survey Reveals Most Patients Are Unaware That Slaughterhouse-Derived Animal Products Are Used in a Majority of IVF Procedures
|
|
Oct 12, 06
|
| 08:00 ET |
Halozyme Therapeutics to Present at the 2006 Bio InvestorForum
|
|
Oct 10, 06
|
| 08:00 ET |
Halozyme Therapeutics Completes Enrollment of Infuse-Morphine Clinical Trial
|
|
Sep 19, 06
|
| 08:00 ET |
Halozyme Therapeutics to Present at the Noble Financial Small Cap Conference
|
|
Sep 13, 06
|
| 08:00 ET |
Halozyme Therapeutics Completes Call of Second Tranche of Warrants From January 2004 Financing
|
|
Aug 29, 06
|
| 08:00 ET |
Halozyme Therapeutics to Present at the Roth 2006 New York Conference
|
|
Aug 10, 06
|
| 08:00 ET |
Halozyme Therapeutics Reports Second Quarter 2006 Financial Results
|
|
Aug 09, 06
|
| 08:00 ET |
Halozyme Therapeutics Calls Second Tranche of Warrants From January 2004 Financing
|
|
Aug 08, 06
|
| 08:00 ET |
Halozyme Therapeutics Initiates First Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Molecule Protein Therapeutic
|
|
Aug 07, 06
|
| 16:00 ET |
Halozyme Therapeutics to Hold 2006 Second Quarter Conference Call on August 10
|
|
Jul 31, 06
|
| 08:00 ET |
Halozyme Therapeutics Names Connie Matsui to Board of Directors
|
|
Jul 26, 06
|
| 08:00 ET |
Halozyme Therapeutics Names Robert Little Chief Commercial Officer
|
|
Jul 12, 06
|
| 16:00 ET |
Halozyme Therapeutics Announces New Studies From HTI-101 Presented at Proteoglycan Research Conference
|
|
Jun 27, 06
|
| 08:00 ET |
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
|
|
Jun 20, 06
|
| 12:24 ET |
Halozyme Therapeutics to Present at the Jefferies Life Sciences Conference
|
|
Jun 01, 06
|
| 21:39 ET |
Halozyme Therapeutics Presents Preclinical and Pharmacokinetic Data on the Subcutaneous Delivery of Antibodies With Enhanze Technology at the 2006 IBC Antibody Conference
|
|
May 23, 06
|
| 08:00 ET |
Halozyme Therapeutics Announces FDA 510(k) Clearance for MediCult's SynVitro Cumulase Product
|
|
May 10, 06
|
| 08:00 ET |
Halozyme Therapeutics Reports First Quarter 2006 Financial Results
|
|
May 09, 06
|
| 08:00 ET |
Halozyme Therapeutics to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference
|
|
May 08, 06
|
| 08:00 ET |
Halozyme Therapeutics Adopts Stockholder Rights Plan
|
|
May 04, 06
|
| 08:00 ET |
Halozyme Therapeutics Announces 22% Increase in IVF ICSI Fertilization Rates in Eggs Treated With Cumulase Versus Bovine Extract
|
|
Apr 26, 06
|
| 08:00 ET |
Halozyme Therapeutics Initiates Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
|
|
Apr 20, 06
|
| 08:00 ET |
Halozyme Therapeutics Receives Approximately $1.9 Million From Exercise of Warrants
|
|
Apr 04, 06
|
| 08:18 ET |
Halozyme Therapeutics Presents Preclinical and Phase I Pharmacokinetic Data for Chemophase at the 2006 American Association for Cancer Research (AACR) Annual Meeting
|
|
Mar 28, 06
|
| 08:04 ET |
Halozyme Therapeutics to Present Preclinical, Toxicology and Phase I Data at the 2006 American Association for Cancer Research (AACR) Annual Meeting
|
|
Mar 23, 06
|
| 08:01 ET |
Halozyme Therapeutics Reports Fourth Quarter and Year End 2005 Financial Results
|
|
Mar 20, 06
|
| 08:03 ET |
Halozyme Therapeutics to Hold 2005 Fourth Quarter and Year End Conference Call on March 23
|
|
Mar 06, 06
|
| 08:01 ET |
Halozyme Therapeutics Completes Enrollment of Chemophase Phase I Clinical Trial for Superficial Bladder Cancer
|
|
Mar 02, 06
|
| 08:03 ET |
Halozyme Therapeutics to Present at the Cowen & Co. 26th Annual Health Care Conference
|
|
Feb 15, 06
|
| 16:00 ET |
Halozyme Therapeutics to Present at Roth Capital Partners 18th Annual OC Conference
|
|
Feb 13, 06
|
| 08:02 ET |
Halozyme Therapeutics Announces Notice of Allowance for Patent Claims to Second Human Enzyme
|
|
Feb 08, 06
|
| 16:07 ET |
Halozyme Therapeutics and Baxter Release Results From the INFUSE-LR Study
|
|
Feb 02, 06
|
| 08:00 ET |
Halozyme Therapeutics Initiates Clinical Trial of Subcutaneous Morphine With Hylenex
|
|
Jan 25, 06
|
| 08:03 ET |
Halozyme Therapeutics to Present at Brean Murray, Carret Small Cap Institutional Investor Conference 2006
|
|
Jan 24, 06
|
| 08:02 ET |
Halozyme Therapeutics Completes Enrollment of INFUSE-LR, a Hylenex Clinical Trial of Subcutaneous Hydration
|
|
Dec 21, 05
|
| 08:01 ET |
Halozyme Therapeutics Announces New Chairman
|
|
Dec 15, 05
|
| 08:02 ET |
Halozyme Therapeutics Initiates Hylenex Clinical Trial of Subcutaneous Hydration
|
|
Dec 13, 05
|
| 18:49 ET |
Halozyme Therapeutics Obtains an Additional Commitment for $1.4 Million in a Registered Direct Offering of Common Stock
|
|
| 08:03 ET |
Halozyme Therapeutics to Raise $16.1 Million in Registered Direct Offering of Common Stock
|
|
Dec 05, 05
|
| 08:08 ET |
Halozyme Therapeutics and Baxter Healthcare Corporation Announce FDA Approval of Hylenex
|
|
Nov 11, 05
|
| 08:00 ET |
Halozyme Therapeutics Reports Third Quarter 2005 Financial Results
|
|
Nov 04, 05
|
| 14:01 ET |
Halozyme Therapeutics to Hold Third Quarter 2005 Conference Call on November 11
|
|
Oct 31, 05
|
| 16:08 ET |
Halozyme Therapeutics to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference
|
|
Oct 27, 05
|
| 16:38 ET |
Halozyme Therapeutics Initiates Chemophase Phase I Clinical Trial for Superficial Bladder Cancer - First Patients Treated
|
|
Sep 27, 05
|
| 08:02 ET |
Halozyme Therapeutics Presents Novel Stroke Data at the 2005 American Neurological Association Annual Meeting
|
|
Sep 26, 05
|
| 08:02 ET |
Halozyme Therapeutics Provides Update on Hylenex New Drug Application
|
|
Aug 29, 05
|
| 08:01 ET |
Halozyme Therapeutics to Present at the Roth Capital Partners New York Conference
|
|
Aug 11, 05
|
| 08:03 ET |
Halozyme Therapeutics Receives FDA Clearance to Initiate Chemophase Clinical Trial
|
|
Aug 08, 05
|
| 08:07 ET |
Halozyme Therapeutics and Baxter Healthcare Corporation Expand Relationship to Include European Union
|
|
| 07:45 ET |
Halozyme Therapeutics Reports Second Quarter 2005 Financial Results
|
|
Jul 27, 05
|
| 16:19 ET |
Halozyme Therapeutics to Hold Second Quarter 2005 Conference Call on August 8
|
|
Jul 20, 05
|
| 08:07 ET |
Halozyme Therapeutics Names Former Assistant Secretary of Defense, Sue Bailey, to Scientific Advisory Board
|
|
Jul 06, 05
|
| 08:05 ET |
Halozyme Therapeutics Names Steve Thornton to Board of Directors
|
|
Jun 30, 05
|
| 08:05 ET |
Halozyme Therapeutics Announces Submission of Investigational New Drug Application for Chemophase
|
|
Jun 22, 05
|
| 08:01 ET |
Halozyme Therapeutics and Reproductive Biology Associates Announce New Clinical Data in IVF: Significantly Increased Fertilization Rates With Cumulase
|
|
Jun 21, 05
|
| 16:15 ET |
Halozyme Therapeutics Announces Clinical Safety and Tolerability Data for rHuPH20 Hyaluronidase Presented at BIO 2005
|
|
Jun 20, 05
|
| 08:06 ET |
Halozyme Therapeutics Announces Launch of Cumulase for In Vitro Fertilization
|
|
Jun 13, 05
|
| 12:41 ET |
Halozyme Therapeutics Scheduled to Join the New Russell Microcap Index
|
|
May 26, 05
|
| 12:28 ET |
Halozyme Therapeutics Announces FDA Acceptance of Hylenex NDA
|
|
May 25, 05
|
| 12:50 ET |
Halozyme Therapeutics to Present at Friedman Billings Ramsey 9th Annual Growth Investor Conference
|
|
May 13, 05
|
| 08:01 ET |
Halozyme Therapeutics Reports First Quarter 2005 Financial Results
|
|
May 05, 05
|
| 14:18 ET |
Halozyme Therapeutics to Hold First Quarter 2005 Conference Call on May 13
|
|
May 04, 05
|
| 12:46 ET |
Halozyme Therapeutics' Enhanze Technology Featured in Drug Delivery Technology
|
|
May 02, 05
|
| 08:01 ET |
Halozyme Therapeutics Presents rHuPH20 Hyaluronidase Preclinical Data at the 2005 Association for Research in Vision and Ophthalmology Annual Meeting
|
|
Apr 27, 05
|
| 12:30 ET |
Halozyme Therapeutics to Present at Rodman & Renshaw Techvest Healthcare Conference
|
|
Apr 19, 05
|
| 16:31 ET |
Halozyme Therapeutics Presents rHuPH20 Hyaluronidase Preclinical Data at the 2005 American Association for Cancer Research
|
|
| 08:03 ET |
Halozyme Therapeutics Receives FDA 510(k) Clearance for Cumulase
|
|
Apr 18, 05
|
| 16:12 ET |
Halozyme Therapeutics Announces rHuPH20 Hyaluronidase Preclinical Data Presented at the 2005 American Society of Cataract & Refractory Surgery Symposium and Congress
|
|
Apr 12, 05
|
| 08:04 ET |
Halozyme Therapeutics Adds Vice President of Clinical Development and Medical Affairs to Management Team
|
|
Apr 06, 05
|
| 08:02 ET |
Halozyme Therapeutics Receives FDA Priority Review for Enhanze SC NDA
|
|
Mar 30, 05
|
| 16:15 ET |
Halozyme Therapeutics and Baxter Healthcare Corporation Expand Relationship to Include Development and Supply Agreement
|
|
Mar 28, 05
|
| 08:00 ET |
Halozyme Therapeutics Files NDA for Enhanze SC
|
|